Загрузка...
Is Cytoreductive Nephrectomy Still a Standard of Care in Metastatic Renal Cell Carcinoma?
Cytoreductive nephrectomy has been an integral part of management in metastatic renal cell carcinoma for patients with good performance status, based on the benefit shown by prospective trials in the interferon era and retrospective trials in the targeted therapies era. Clinical Trial to Assess the...
Сохранить в:
| Опубликовано в: : | J Kidney Cancer VHL |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Codon Publications
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6403966/ https://ncbi.nlm.nih.gov/pubmed/30881867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15586/jkcvhl.2019.114 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|